Lactate dehydrogenase and hemolysis in sickle cell disease.
作者信息
Kato Gregory J, Nouraie Seyed Mehdi, Gladwin Mark T
出版信息
Blood. 2013 Aug 8;122(6):1091-2. doi: 10.1182/blood-2013-05-505016.
Abstract
摘要
相似文献
1
Lactate dehydrogenase and hemolysis in sickle cell disease.镰状细胞病中的乳酸脱氢酶与溶血
Blood. 2013 Aug 8;122(6):1091-2. doi: 10.1182/blood-2013-05-505016.
2
Lactate dehydrogenase and hemolysis in sickle cell disease.镰状细胞病中的乳酸脱氢酶与溶血
Blood. 2013 Jan 3;121(1):243-4. doi: 10.1182/blood-2012-10-462135.
3
Lactate dehydrogenase isoenzyme 3 and hemolysis in sickle cell anemia: a possible correlation?
Blood. 2015 Jun 11;125(24):3821-2. doi: 10.1182/blood-2015-04-641522.
4
Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease.乳酸脱氢酶与碳氧血红蛋白比值作为血红素释放至血红素处理过程的生物标志物，与镰状细胞病中较高的三尖瓣反流射流速度及早期死亡相关。
Am J Hematol. 2021 Sep 1;96(9):E315-E318. doi: 10.1002/ajh.26243. Epub 2021 Jun 10.
5
Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain.镰状细胞贫血中的慢性高溶血：血管并发症及死亡率与较少发生的血管阻塞性疼痛的关联。
PLoS One. 2008 May 7;3(5):e2095. doi: 10.1371/journal.pone.0002095.
6
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.乳酸脱氢酶作为镰状细胞病患者溶血相关一氧化氮抵抗、阴茎异常勃起、腿部溃疡、肺动脉高压和死亡的生物标志物。
Blood. 2006 Mar 15;107(6):2279-85. doi: 10.1182/blood-2005-06-2373. Epub 2005 Nov 15.
7
Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.年轻镰状细胞病患者的生长分化因子-15：与溶血、铁过载及血管并发症的关系
Blood Cells Mol Dis. 2014 Dec;53(4):189-93. doi: 10.1016/j.bcmd.2014.07.003. Epub 2014 Jul 25.
8
Endothelial Nitric Oxide Synthase (eNOS) Gene Polymorphisms and Markers of Hemolysis, Inflammation and Endothelial Dysfunction in Brazilian Sickle Cell Anemia Patients.巴西镰状细胞贫血患者内皮型一氧化氮合酶（eNOS）基因多态性及溶血、炎症和内皮功能障碍标志物。
Biochem Genet. 2020 Aug;58(4):580-594. doi: 10.1007/s10528-020-09959-w. Epub 2020 Apr 10.
9
Lactate dehydrogenase in sickle cell disease.镰状细胞病中的乳酸脱氢酶。
Clin Chim Acta. 2016 Jul 1;458:99-102. doi: 10.1016/j.cca.2016.04.035. Epub 2016 Apr 29.
10
Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.刚果患者镰状细胞贫血临床严重程度中乳酸脱氢酶水平与实验室变量的相关性
PLoS One. 2015 May 6;10(5):e0123568. doi: 10.1371/journal.pone.0123568. eCollection 2015.
引用本文的文献
1
Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.补充精氨酸可改善稳态镰状细胞病患者的乳酸脱氢酶水平：来自刚果民主共和国金沙萨的初步研究结果。
Front Pain Res (Lausanne). 2024 Nov 22;5:1391666. doi: 10.3389/fpain.2024.1391666. eCollection 2024.
2
Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease.太空和微重力对镰状细胞病红细胞的基因-环境影响。
NPJ Genom Med. 2024 Sep 30;9(1):44. doi: 10.1038/s41525-024-00427-7.
3
Association between fetal hemoglobin, lactate dehydrogenase, and disease severity in patients with sickle cell disease at Bugando Medical Centre, Mwanza, Tanzania.坦桑尼亚姆万扎布甘多医学中心镰状细胞病患者胎儿血红蛋白、乳酸脱氢酶与疾病严重程度的关系。
PLoS One. 2024 Jul 15;19(7):e0286891. doi: 10.1371/journal.pone.0286891. eCollection 2024.
4
Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease.血红蛋白清道夫受体 CD163 作为镰状细胞病溶血诱导肝胆损伤的潜在生物标志物。
Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C423-C437. doi: 10.1152/ajpcell.00386.2023. Epub 2024 Apr 29.
5
Clinical Biomarkers of Acute Vaso-Occlusive Sickle Cell Crisis.急性血管闭塞性镰状细胞危象的临床生物标志物
Cureus. 2024 Mar 18;16(3):e56389. doi: 10.7759/cureus.56389. eCollection 2024 Mar.
6
Kidney R2* Mapping for Noninvasive Evaluation of Iron Overload in Paroxysmal Nocturnal Hemoglobinuria.肾脏R2*成像用于阵发性夜间血红蛋白尿中铁过载的无创评估。
Magn Reson Med Sci. 2025 Apr 1;24(2):204-209. doi: 10.2463/mrms.mp.2023-0114. Epub 2024 Feb 16.
7
Iron Chelation Reduces DNA Damage in Sickle Cell Anemia.铁螯合作用可降低镰状细胞贫血症中的 DNA 损伤。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211047230. doi: 10.1177/10760296211047230.
8
Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.血红素结合蛋白介导的细胞保护在镰状细胞病病理生理学中的关键作用。
Int J Mol Sci. 2021 Jun 15;22(12):6408. doi: 10.3390/ijms22126408.
9
Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.多血统全基因组关联研究鉴定出 27 个与血液储存后溶血测量值相关的位点。
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI146077.
10
Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease.镰状细胞病患者对氧磷酶（PON）1、2和3的多态性及PON-1活性
Antioxidants (Basel). 2019 Jul 30;8(8):252. doi: 10.3390/antiox8080252.
本文引用的文献
1
Lactate dehydrogenase and hemolysis in sickle cell disease.镰状细胞病中的乳酸脱氢酶与溶血
Blood. 2013 Jan 3;121(1):243-4. doi: 10.1182/blood-2012-10-462135.
2
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.美国和欧洲 415 例镰状细胞贫血患者的溶血严重程度、临床表现与死亡风险之间的关系。
Haematologica. 2013 Mar;98(3):464-72. doi: 10.3324/haematol.2012.068965. Epub 2012 Sep 14.
3
High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients.入院时乳酸脱氢酶水平升高与成人 SCD 患者发生严重血管阻塞性危象相关。
Clin Biochem. 2012 Dec;45(18):1578-82. doi: 10.1016/j.clinbiochem.2012.07.114. Epub 2012 Aug 8.
4
Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.载脂蛋白 A-I 和血清淀粉样蛋白 A 血浆水平是镰状细胞病患者急性疼痛发作的生物标志物。
Haematologica. 2010 Sep;95(9):1467-72. doi: 10.3324/haematol.2009.018044. Epub 2010 Apr 7.
5
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.循环红细胞衍生的微粒与镰状细胞病中的凝血激活有关。
Haematologica. 2009 Nov;94(11):1513-9. doi: 10.3324/haematol.2009.008938. Epub 2009 Oct 8.
6
Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia.镰状细胞贫血患者单纯急性疼痛发作演变过程中的高溶血现象。
Transfusion. 2006 Jan;46(1):105-10. doi: 10.1111/j.1537-2995.2006.00679.x.
7
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.乳酸脱氢酶作为镰状细胞病患者溶血相关一氧化氮抵抗、阴茎异常勃起、腿部溃疡、肺动脉高压和死亡的生物标志物。
Blood. 2006 Mar 15;107(6):2279-85. doi: 10.1182/blood-2005-06-2373. Epub 2005 Nov 15.
8
Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease.
Am J Clin Pathol. 1969 Aug;52(2):167-9. doi: 10.1093/ajcp/52.2.167.
9
Serum-alpha-hydroxybutyrate dehydrogenase levels in sickle-cell disease and sickle-cell crisis.
Lancet. 1978 Mar 11;1(8063):532-3. doi: 10.1016/s0140-6736(78)90554-8.
Zotero 插件